Recent data show that BCR components are frequently mutated in human leukemia (Davis et al., 2010) and that an autonomously signaling BCR can act as a tumor promoter for B cell chronic lymphocytic leukemia (Duhren-von Minden et al., 2012). This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.